Lymphoblastic Lymphoma — Trials

Lymphoblastic Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

263 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 58
Recruiting: 35
Ph III recruiting: 2
Growth YoY: —
Industry share: 10%
Top sponsor: City of Hope Medical Center
Termination share: 37%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03558412	A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma	unknown	Phase 4	40	Mingzhi ZhangOTHER	1	Sep 14, 2018	clinicaltrials
NCT02938741	ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors	unknown	Phase 4	130	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Oct 25, 2016	clinicaltrials